Abcam Share Price (ABC)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Abcam Plc	LSE:ABC	London	Ordinary Share	GB00B6774699	ORD 0.2P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	+11.00p	+0.78%	1,422.00p	337,459	16:35:07

Bid Price		Offer Price	High Price	Low Price	Open Price
1,419.00p		1,421.00p	1,427.00p	1,408.00p	1,419.00p

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	233.20	69.10	30.50	46.6	2,923.6

Related Shares
Glaxosmithkline (GSK), Astrazeneca (AZN), Venn Life Sciences (VENN), Valirx (VAL)

Abcam (ABC) Latest News

Abcam News

Date	Time	Source	Headline
02/5/2019	12:53	UKREG	ABCAM PLC Total Voting Rights
01/5/2019	07:00	UKREG	ABCAM PLC Appointment of Joint Broker
02/4/2019	13:13	UKREG	ABCAM PLC Total Voting Rights
29/3/2019	07:02	UKREG	ABCAM PLC Company Secretary Change
25/3/2019	05:59	ALNCF	Alliance News Flash Headline
12/3/2019	18:00	ALNC	Standard Life Aberdeen Aggregate Now Holds 5.1% Stake In Abcam (ALLISS)
12/3/2019	07:02	UKREG	ABCAM PLC Holding(s) in Company
08/3/2019	08:57	UKREG	ABCAM PLC Holding(s) in Company
04/3/2019	09:24	ALNC	Abcam Shares Fall On Annual Outlook Despite Profit, Revenue Growth
04/3/2019	07:00	UKREG	ABCAM PLC Interim results for six months ended 31 Dec 2018

More Abcam News

Abcam Takeover Rumours

Abcam (ABC) Share Charts

1 Year Abcam Chart

1 Month Abcam Chart

Intraday Abcam Chart

Abcam (ABC) Discussions and Chat

Abcam Forums and Chat

Date	Time	Title	Posts
16/5/2019	12:04	ABCAM with Charts & News	102
19/11/2017	20:07	Investing ? Start with your ABC's	703
03/8/2017	11:31	Abcam	-
29/8/2013	23:08	ABCAM - another e-Commerce Retailer	120
07/2/2013	17:29	abc	1

Add a New Thread

Abcam (ABC) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
2019-05-24 16:44:32	1,418.51	4,349	61,690.78	O
2019-05-24 16:24:20	1,422.00	576	8,190.72	O
2019-05-24 16:18:13	1,418.00	1	14.18	O
2019-05-24 16:18:13	1,418.19	26	368.73	O
2019-05-24 16:15:00	1,419.39	1,148	16,294.63	O

View all Abcam trades in real-time

Abcam (ABC) Top Chat Posts

Date	Subject
25/5/2019 09:20	Abcam Daily Update: Abcam Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker ABC. The last closing price for Abcam was 1,411p. Abcam Plc has a 4 week average price of 1,254p and a 12 week average price of 1,058p. The 1 year high share price is 1,588p while the 1 year low share price is currently 1,006p. There are currently 205,597,614 shares in issue and the average daily traded volume is 446,555 shares. The market capitalisation of Abcam Plc is £2,923,598,071.08. Read Full Thread Reply
05/3/2019 15:26	erogenous jones: Not in the least fussed about the drop yesterday, or the rise today, for that matter. Good, well managed and profitable company that has a track record of share price growth over many years. That was the case last week and remains the case this week. My average price is £6.50 and until the company ceases to be as profitable as in previous years I see no reason why I should not allow profits to run. Read Full Thread Follow Reply
12/12/2018 16:05	investorschampion: Milner's wife recently bought £2m worth of shares. It's a nice confidence booster following the recent share price weakness, but perhaps some executive directors should follow suit? hxxps://www.investorschampion.com/channel/blog/follow-the-directors-whos-buying Read Full Thread Follow Reply
07/12/2018 11:31	jurgenklopp: With regards to the large PDMR purchase yesterday it should be noted that Milner sold over 1 million shares at £14.41 as recently as late September. However re-investing 2 million quid back in company shares ought to provide some kind of support to the share price in these strange times !! Read Full Thread Follow Reply
03/11/2016 11:09	shawzie: I can only agree with Panmure that the current share price overvalues this Company. Earnings fairly static on increasing turnover. Intangibles increasing rapidly, but not reflected in increased earnings. Increase in Net Worth of Company due mainly to increase in Intangibles. Does anyone have a more optimistic view? Read Full Thread Follow Reply
25/1/2016 11:48	campbed: Very good trading update today outlining progress on all fronts. A great British success story . Share price at 640p almost back to the all time high of 660p reached at end of 2015 before the market-wide Jan sell off. Read Full Thread Follow Reply
31/1/2015 10:42	apad: Slater in the Telegraph today - with any luck that should drive the share price down for those who are looking for an entry point. apad . .R01;and some can be disastrous Other Aim shares that are favourites of veteran IHT investors are Young & Co’s Brewery, Advanced Medical Solutions and Abcam. All three are good sound companies but it seems to me that their share prices are living on the memory of their excellent past growth. Nowadays their p/e ratios are in or around the 20s with only single-digit earnings growth forecast. They are not for me because the slightest upset in their earnings growth could cause a major setback in their shares. Read Full Thread Follow Reply
22/1/2015 17:43	jeffcranbounre: Abcam is featured in today's ADVFN podcast. To listen to the podcast click here> http://bit.ly/ADVFN0113 In today's podcast: - Chris Oil, financial writer and city investor will be chatting about a well known name who could be back in fashion. Chris on Twitter is @ChrisOil - And Rodney Hobson, a financial speaker, writer and author of investment books including Shares Made Simple, the beginner's guide to the stock market. Rodney on Twitter is @RodneyHobson - The micro and macro news - Plus the broker forecasts Every Tuesday is Ten Bagger Tuesday on the podcast. If you know of a stock, whose share price has the potential to increase ten fold, just click the link below. Ten Bagger Tuesday (All it involves is filling out a form that will take you around 5 minutes and you don't personally appear on the podcast). Once a week, on a Friday, I feature a tip from a listener to this podcast, if you'd like to suggest a stock click the link below: Suggest a stock (Again all it involves is filling out a form that will take you around 5 minutes and you don't personally appear on the podcast). You can subscribe to this podcast in iTunes by clicking HERE To follow me on Twitter click HERE As a listener to the ADVFN podcast you can take advantage of some exclusive first year discounts on popular subscriptions: Bronze - £50 (normally £73.82/year) Silver - £145 (normally £173.71/year) Level 2 - £350 (normally £472.94/year) Call 0207 0700 961 and ask for the ADVFN Podcast discount to take advantage of these reduced rates or just CLICK HERE for more information. Please DO NOT buy any stock recommended in this podcast basely solely on what you hear. The opinions in this podcasts are just that, opinions. Please do you own research before investing. Justin Read Full Thread Follow Reply
22/1/2015 17:24	richscotsman: Abcam may well have it's ups and downs.... Look at the chart and it is mainly up. They do however have unique capability in a market which has long term grant funding... For me this is a safer bet in a downturn than gold but also okay generally. The fact that the bod take a view of future markets and invest in a company that they can add value to is positive. What may cost in the short term is wise in the long term. They could easily have made no progress by cutting overheads to a minimum in search of short term share price reward. The acquisition is further evidence of bod that understands the future market and can close a deal. Strip out currency and the growth is stunning. If you look forward then those currency trends may well reverse. Read Full Thread Follow Reply
20/5/2014 07:56	simon gordon: Unicorn AIM VCT - 20/5/14 Abcam (-23%) is a global leader in the supply of innovative protein research tools. In March 2014, Abcam released its financial results for the six month period ended 31 December 2013, which were in line with your Investment Manager's internal forecasts. Revenues of £61.9m (H2 2012: £57.3m) represented half-year on half-year growth of over 8%, while earnings per share were up 6.5% to 8.74p (H2 2012: 8.21p). Abcam remains a cash generative business with a robust balance sheet. Net cash balances at the period end amounted to £35.3m. Despite Abcam's many obvious qualities, market reaction to the release of Interim Results in early March was negative as investors worried about currency headwinds and the impact of possible cuts to health budgets in the key North American market, which accounts for 43% of total sales. As a result, Abcam's share price ended the period markedly lower. The holding has been retained in the portfolio in the expectation that the de-rating in the value of Abcam will prove to be temporary. Read Full Thread Follow Reply
06/3/2014 07:27	richscotsman: Buy into Abcam as share price drops, says Numis Antibody supplier Abcam (ABC.L) has been upgraded from 'hold' to 'buy' by Numis analyst Charles Weston. Weston placed a target price of 510p on the shares despite a sharp drop in the share price earlier in the week as it revealed sluggish Japanese growth despite the Japanese government investing in research. 'We are upgrading our recommendation to 'buy', from 'hold', following the sharp fall in the share price [on Wednesday morning],' he said. 'In our view little has changed in the fundamental investment thesis for Abcam and history has taught us that periods of weakness in its share price are the right time to buy into its highly defensive business model.' Weston said he 'expected margins and cash generation to remain high due to the characteristics of the product and Abcam's digital platform' and that management's investment in new growth initiatives has 'yet to translate to accelerating growth rates, which could start to be delivered over the next six-12 months'. Read Full Thread Follow Reply

Abcam share price data is direct from the London Stock Exchange

Your Recent History

LSE

ABC

Abcam

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P: V: D:20190525 07:51:12